STOCK TITAN
  1. Home
  2. Sec-filings
  3. CACI
  4. [Form 4] CACI INTERNATIONAL INC /DE/ Insider Trading Activity

CACI insider filing: Plunkett adds 83 shares; total now 2,564

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CACI International Inc. (CACI) reported an insider equity change by director Debora A. Plunkett. On October 12, 2025, 83 shares of CACI common stock were acquired via an RSU vesting event (transaction code M). Following this transaction, Ms. Plunkett beneficially owned 2,564 shares, held directly.

The activity relates to a prior grant of 331 Restricted Stock Units awarded on October 17, 2024, with scheduled vesting as follows: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.

Positive

  • None.

Negative

  • None.
Insider Plunkett Debora A
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 83 $0.00 --
Exercise CACI Common Stock 83 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); CACI Common Stock — 2,564 shares (Direct)
Footnotes (1)
  1. [object Object]
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Plunkett Debora A
(Last) (First) (Middle)
12021 SUNSET HILLS ROAD
(Street)
RESTON VA 20190
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CACI INTERNATIONAL INC /DE/ [ CACI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
CACI Common Stock 10/12/2025 M 83 A (1) 2,564 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/12/2025 M 83 (1) (1) CACI Common Stock 83 (1) 0 D
Explanation of Responses:
1. On October 17, 2024, Ms. Plunkett was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
Remarks:
Debora A. Plunkett 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did CACI (CACI) report in this insider filing?

Director Debora A. Plunkett acquired 83 CACI common shares on October 12, 2025 via an RSU vesting (code M).

How many CACI shares does Debora A. Plunkett own after the transaction?

She beneficially owned 2,564 shares directly following the reported transaction.

What was the source of the 83 CACI shares acquired?

They were delivered upon vesting from previously granted Restricted Stock Units (RSUs), as indicated by transaction code M.

When were the RSUs originally granted to the CACI director?

The RSUs were granted on October 17, 2024, totaling 331 units.

What is the RSU vesting schedule disclosed for the CACI grant?

Vesting was scheduled for 82 shares on Jan 15, 2025, and 83 shares on Apr 15, 2025, Jul 14, 2025, and Oct 12, 2025.

What transaction code is shown for the CACI insider event?

The filing shows transaction code M for the October 12, 2025 event.